Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4440335
Max Phase: Preclinical
Molecular Formula: C56H90F15N19O17S
Molecular Weight: 1048.38
Molecule Type: Unknown
Associated Items:
ID: ALA4440335
Max Phase: Preclinical
Molecular Formula: C56H90F15N19O17S
Molecular Weight: 1048.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCCCC(=O)N(CCNC(=O)[C@H](Cc1c[nH]cn1)N(CCNC(=O)[C@H](CCCNC(=N)N)N(CCN)C(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)CCCCCN)[C@@H](CCCCN)C(N)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C46H85N19O7S.5C2HF3O2/c47-17-7-1-2-14-39(68)65(35(27-31-28-55-30-60-31)43(71)57-22-25-64(33(41(50)69)11-5-8-18-48)38(67)16-6-9-20-58-44(51)52)26-23-56-42(70)34(12-10-21-59-45(53)54)63(24-19-49)37(66)15-4-3-13-36-40-32(29-73-36)61-46(72)62-40;5*3-2(4,5)1(6)7/h28,30,32-36,40H,1-27,29,47-49H2,(H2,50,69)(H,55,60)(H,56,70)(H,57,71)(H4,51,52,58)(H4,53,54,59)(H2,61,62,72);5*(H,6,7)/t32-,33-,34-,35-,36-,40-;;;;;/m0...../s1
Standard InChI Key: SLHPOUAMXARWCW-GLDQKVSOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1048.38 | Molecular Weight (Monoisotopic): 1047.6600 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Nguyen HT, Guégan JP, Poissonnier A, Jouan F, Best D, van de Weghe P, Vacher P, Levoin N, Legembre P, Jean M.. (2019) Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis., 29 (16): [PMID:31301931] [10.1016/j.bmcl.2019.07.006] |
Source(1):